{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "COVID-19 drug treatment",
      "SARS-CoV-2",
      "hematologic neoplasms",
      "monoclonal antibodies"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34337739",
  "DateCompleted": {
    "Year": "2022",
    "Month": "01",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "08",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/bjh.17756"
    ],
    "Journal": {
      "ISSN": "1365-2141",
      "JournalIssue": {
        "Volume": "196",
        "Issue": "1",
        "PubDate": {
          "Year": "2022",
          "Month": "Jan"
        }
      },
      "Title": "British journal of haematology",
      "ISOAbbreviation": "Br J Haematol"
    },
    "ArticleTitle": "Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia.",
    "Pagination": {
      "StartPage": "e1",
      "EndPage": "e3",
      "MedlinePgn": "e1-e3"
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-6327-0898"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Aix Marseille Univ, INSERM, INRAe, C2VN, Marseille, France."
          }
        ],
        "LastName": "Saultier",
        "ForeName": "Paul",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit\u00e9 des Virus \u00c9mergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, H\u00f4pitaux Universitaires de Marseille, Marseille, France."
          }
        ],
        "LastName": "Ninove",
        "ForeName": "Laetitia",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France."
          }
        ],
        "LastName": "Szepetowski",
        "ForeName": "Sarah",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France."
          }
        ],
        "LastName": "Veneziano",
        "ForeName": "Mathilde",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France."
          }
        ],
        "LastName": "Visentin",
        "ForeName": "Sandrine",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France."
          }
        ],
        "LastName": "Barlogis",
        "ForeName": "Vincent",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit\u00e9 des Virus \u00c9mergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, H\u00f4pitaux Universitaires de Marseille, Marseille, France."
          }
        ],
        "LastName": "Saba Villarroel",
        "ForeName": "Paola Mariela",
        "Initials": "PM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit\u00e9 des Virus \u00c9mergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, H\u00f4pitaux Universitaires de Marseille, Marseille, France."
          }
        ],
        "LastName": "Amroun",
        "ForeName": "Abdennour",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0002-8372-4148"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Hematology, APHM, La Timone Hospital, Marseille, France."
          }
        ],
        "LastName": "Loosveld",
        "ForeName": "Marie",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit\u00e9 des Virus \u00c9mergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, H\u00f4pitaux Universitaires de Marseille, Marseille, France."
          }
        ],
        "LastName": "de Lamballerie",
        "ForeName": "Xavier",
        "Initials": "X"
      },
      {
        "Identifier": [
          "0000-0002-5319-1969"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Aix Marseille Univ, INSERM, INRAe, C2VN, Marseille, France."
          }
        ],
        "LastName": "Chambost",
        "ForeName": "Herv\u00e9",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Haematol",
    "NlmUniqueID": "0372544",
    "ISSNLinking": "0007-1048"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Monoclonal, Humanized"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Neutralizing"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "45I6OFJ8QH",
      "NameOfSubstance": "bamlanivimab"
    },
    {
      "RegistryNumber": "N7Q9NLF11I",
      "NameOfSubstance": "etesevimab"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antibodies, Monoclonal, Humanized"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antibodies, Neutralizing"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Leukemia"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors have no competing interests to disclose."
}